Orange Book product · Generic (ANDA)
SODIUM NITROPRUSSIDE
SODIUM NITROPRUSSIDE
At a glance
Apr 10, 2019
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 10, 2019
7 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
SODIUM NITROPRUSSIDE
Strength
25MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 210114
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of SODIUM NITROPRUSSIDE
- 2017NIPRIDE RTU IN SODIUM CHLORIDE 0.9%Brand (NDA)
NDA 209387 · EXELA PHARMA
- 1982SODIUM NITROPRUSSIDEBrand (NDA)
NDA 018581 · BAXTER HLTHCARE
- —NIPRIDEBrand (NDA)
NDA 017546 · ROCHE
- —NITROPRESSBrand (NDA)
NDA 018450 · ABBVIE
- 2022SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 208923 · AVET LIFESCIENCES
- 2022SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 215846 · SLATE RUN PHARMA
- 2021SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 214971 · BE PHARMS
- 2020SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 211934 · EUGIA PHARMA
- 2020SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 211277 · XIROMED
- 2020SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 214199 · SLATE RUN PHARMA
- 2019SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 211016 · CAPLIN
- 2018SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 210467 · SUN PHARM
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
